Analytical Data
-
Gene name
SDF1
- Application
-
Alternative Names
CXCL12; PBSF; P-BSF; SCYB12; SDF1-A; SDF1-B; SDF1A; SDF1B; TLSF-A; TLSF-B; TPAR1; Pre-B Cell Growth-Stimulating Factor; Chemokine C-X-C-Motif Ligand 12
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P48061
-
Expression Region
Pro23~Lys89
-
Molecular Weight
9kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SDF1 (Stromal Derived Factor 1) is a chemokine that plays a critical role in cellular processes such as immune response, hematopoiesis, and angiogenesis. It primarily functions by guiding the migration and homing of various cell types, including stem cells and immune cells, to specific tissues during development and in response to injury or inflammation. Given its significant role in these biological processes, SDF1 has gained attention in therapeutic research, particularly in the fields of regenerative medicine and cancer treatment. Recombinant SDF1 proteins have been developed to study their effects on cell migration and differentiation, as well as to investigate their potential applications in promoting tissue repair and modulating immune responses. Researchers are exploring SDF1's interactions with its receptor, CXCR4, to better understand the underlying mechanisms of diseases such as cancer metastasis and HIV infection. By producing and characterizing recombinant SDF1, scientists aim to uncover new strategies for using this protein in clinical applications, including enhancing stem cell therapy, improving wound healing, and developing targeted cancer therapies. The ongoing research into SDF1 recombination not only provides insights into fundamental biological processes but also holds promise for innovative therapeutic approaches to address a variety of health challenges.
